Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Vor Biopharma Inc.

United States 500 Boylston Street Suite 1350, 02116-3740, United States

About the sponsor

Vor Biopharma Inc. is involved in clinical research for generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder marked by impaired communication between nerves and muscles.

  • Generalized myasthenia gravis
  • Autoimmune neuromuscular disease
  • Muscle weakness

The sponsor’s research activity in this area is centered on treatment options for patients with widespread symptoms affecting multiple muscle groups.

About Specializations

Vor Biopharma Inc. runs clinical trials in conditions such as Sjogren's syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Sjogren's syndrome

Not yet recruiting

Phase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Telitacicept
  • Sponsor:Vor Biopharma Inc.

Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Telitacicept
  • Sponsor:Vor Biopharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.